Application no. and date | 14763104.8 (espacenet) (Federated) (European Patent Register), 20140317 | Patent/reg. no. and date | DK/EP 2968443, 20210929 | Publication date | 20160120 | Priority no. and date | US 201361800284 P, 20130315, US 201361800048 P, 20130315 | EP pub. no. and date |
EP 2968443 20160120 | Effective date | | Applicant/owner | Protagonist Therapeutics, Inc., 7707 Gateway Boulevard, Suite 140
Newark, CA 94560-1160, US | Applicant ref. no. | P3077DKEP | Inventor | FREDERICK, Brian T., 8470 Glen Arbor Road
Ben Lomond, CA 95005, US, SMYTHE, Mark Leslie, 8 Morgan Terrace
Bardon, Queensland 4065, AU, BOURNE, Gregory Thomas, 29 Moolingal Street
Jindalee, Queensland 4074, AU, VINK, Simone, 5/70 Swann Road
Taringa, Queensland 4068, AU, MADALA, Praveen, 55-Bilkurra Street Middle Park
Brisbane, Queensland 4074, AU, TOFTENG SHELTON, Anne Pernille, Prisholmvej 40, 2500 Valby, DK, FOG, Jacob Ulrik, Vaerebrovej 194, 2880 Bagsværd, DK | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | Opponent | | IPC Class | A61K 38/00 (2006.01) , A61P 3/00 (2006.01) , A61P 3/12 (2006.01) , C07K 14/575 (2006.01) | Title | HEPCIDINANALOGER OG ANVENDELSER DERAF | Int. application no. | US2014030352 | Int. publication no. | WO2014145561 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|